deltatrials
Completed PHASE4 NCT00400621

Effects of Therapeutic Doses of Acetaminophen in Moderate Drinkers

Assessment of Hepatic Injury in Subjects Who Consume Moderate Amounts of Alcohol While Being Administered Therapeutic Doses of Acetaminophen:

Sponsor: Denver Health and Hospital Authority

Conditions Moderate Alcohol Consumption (1-3 Drinks Per Day)
Interventions acetaminophen
Updated 5 times since 2017 Last updated: Jul 3, 2024 Started: Apr 30, 2003 Completion: Sep 30, 2003

A PHASE4 clinical study on Moderate Alcohol Consumption (1-3 Drinks Per Day), this trial is completed. The trial is conducted by Denver Health and Hospital Authority and has accumulated 5 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Aug 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jul 2024 — Aug 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jan 2021 [monthly]

    Completed PHASE4

    First recorded

Apr 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Denver Health and Hospital Authority
  • McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Data source: Denver Health and Hospital Authority

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.